PCOS Gets a New Name: Why It’s Now Called PMOS

A major change has been announced in women’s health. Polycystic Ovary Syndrome (PCOS), a condition that affects an estimated 1 in 8 women worldwide, has been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) following a global expert consensus published on May 12, 2026, in The Lancet. The change was supported by international health organizations, clinicians, researchers, and patients who said the old name did not accurately reflect the true nature of the condition. For millions of people living with PCOS, this is more than just a name change. It represents a broader and more accurate understanding of a disorder that affects far more than the ovaries.

Also Read: What Is Hantavirus and How Does It Spread?

Why the Name Was Changed

For many years, the name Polycystic Ovary Syndrome led many people to believe that the condition was mainly about cysts in the ovaries. However, experts say this understanding is incomplete and misleading. Research over the past two decades has shown that PCOS is not simply an ovarian condition, but a complex endocrine and metabolic disorder that can affect multiple systems in the body, including menstrual health, fertility, insulin regulation, cardiovascular health, skin, hair, weight, and mental well-being. According to Dr. Helena Teede, an endocrinologist at Monash Health in Australia and one of the lead authors behind the consensus, the old name often caused confusion because it failed to describe the condition accurately. The decision to rename the condition followed years of global consultation and research, with more than 14,000 patients and healthcare professionals contributing feedback. Strong support emerged for a name that better reflected the full range of symptoms and health effects associated with the condition.

Why the New Name Is PMOS

The new name, Polyendocrine Metabolic Ovarian Syndrome, was chosen to better reflect the condition’s true complexity. The term “polyendocrine” indicates that the disorder affects multiple hormone systems in the body, while “metabolic” highlights its impact on insulin function, blood sugar regulation, energy balance, and weight. “Ovarian” remains part of the name because ovarian dysfunction remains an important clinical feature, even though the ovaries are not the only organs involved. The word “syndrome” reflects the fact that the condition is a group of related symptoms and health effects that occur together. Experts believe the new terminology provides a clearer understanding for both patients and healthcare providers by recognizing PMOS as a multisystem condition rather than simply an ovarian disorder.

You Do Not Need Ovarian Cysts to Have PMOS

One of the biggest misunderstandings caused by the old name involved the word “polycystic,” which led many people to assume that ovarian cysts were required for diagnosis. However, this is not correct. What many patients have instead are multiple immature ovarian follicles, which are small fluid-filled sacs involved in egg development. In some cases, these follicles do not mature properly or release an egg during ovulation, causing them to accumulate and appear on ultrasound scans. These are not the same as pathological ovarian cysts that may require separate medical treatment. This confusion has contributed to unnecessary anxiety, delayed diagnosis, and misunderstanding among patients for years.

Also Read: Can “Office Air” Really Affect Your Skin and Hair?

The Real Problem Is Hormones and Metabolism

Experts now recognize that the condition involves much more than ovarian function alone. The exact cause is not fully understood, but genetic, hormonal, metabolic, and environmental factors are believed to contribute. People with PMOS may face an increased risk of insulin resistance, type 2 diabetes, cardiovascular disease, infertility, weight management difficulties, mood disorders such as anxiety and depression, and endometrial abnormalities, including a higher risk of cancer. Common symptoms may include irregular or absent menstrual periods, difficulty becoming pregnant, excess facial or body hair, acne, thinning scalp hair, fatigue, weight gain, difficulty losing weight, and mood changes. Because the condition affects far more than reproductive health, many patients have long felt that the old name failed to reflect their real experiences.

How the Old Name Affected Medical Care

Experts believe the previous name may have contributed to misunderstanding within healthcare systems. Because the condition was often viewed primarily as a reproductive or fertility disorder, other important health risks sometimes received less attention. Some specialists argue that the misleading terminology contributed to fragmented care, delayed diagnosis, under-recognition of metabolic complications, and limited awareness among healthcare providers. This may help explain why many patients report feeling dismissed, misunderstood, or inadequately treated when seeking medical care.

What Happens Next?

Although the new name has been adopted through international consensus, the transition will take time. Experts estimate that widespread implementation across healthcare systems may take approximately three years. This process will involve updating medical records, diagnostic classifications, treatment guidelines, insurance coding systems, educational materials, and clinical training resources. During this transition period, both PCOS and PMOS may continue to appear in healthcare settings. Patients should not be alarmed if they continue seeing the older terminology, as healthcare systems will gradually adapt over time.

Also Read: 4 Common Cruise Ship Illnesses to Know About

Will Treatment Change?

The condition itself has not changed. Anyone previously diagnosed with PCOS still has the same medical condition, but it may now be described more accurately under the new name. Current treatment approaches are expected to remain broadly similar in the short term, depending on individual symptoms and needs. These may include lifestyle interventions, weight management support, medications to improve insulin sensitivity, hormonal treatments, fertility care, and mental health support. However, experts hope that broader recognition of the condition’s full health impact will improve treatment in the future. Instead of focusing mainly on fertility, future care may increasingly involve coordinated treatment addressing metabolic, cardiovascular, reproductive, and psychological health, with support from gynecologists, endocrinologists, primary care physicians, mental health professionals, and other specialists.

A Step Toward Better Understanding

The change from PCOS to PMOS represents far more than a simple terminology update. It reflects a major shift in how medicine understands the condition. For years, many patients felt that the old name minimized or misrepresented their symptoms by focusing too narrowly on ovarian findings. The new terminology aims to better reflect the true complexity of the disorder and encourage earlier diagnosis, stronger research, improved medical education, and more comprehensive patient care. For those already diagnosed, the central message remains simple: the condition itself has not changed, but medical understanding of it has evolved.